Answer
Selexipag can lower blood pressure through its vasodilatory properties, so prescribers should carefully consider whether patients with underlying conditions could be adversely affected.
Sources for this answer
- Uptravi 200 microgram film-coated tablets (Great Britain)Janssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.4 Special warnings and precautions for use · Version 19Document updated
Sources checked